retatrutide parkinson's disease 🎙️ NEW EPISODE: Retatrutide—The Triple Agonist *Not licensed* Will this replace the current GLP-1 in the market., This triple receptor agonist (GIP/GLP-1/glucagon) is showing unprecedented results in Eli Lilly's Phase 3 data

This isnt medical magic its sophisticated biochemistry

Triglyceride-rich lipoproteins can directly contribute to plaque formation

Very little exists for what happens after

Pharmacological treatment with Ex-4 delivered to the VTA in overnight food-deprived rats reduces one-hour sucrose intake, 24 h chow intake, and 24 h body weight

Both semaglutide and tirzepatide followed similar paths to the one retatrutide is on now

In This Episode, We Cover: The stress of managing two chronic conditions: celiac disease and type 1 diabetes Lorins experience using GLP-1 medications What to consider if youre curious about GLP-1s and you have celiac or type 1 diabetes Her experiences building a gluten-free social media following, podcast, and local community Listen to the full episode on Gluten Free Unwrapped wherever you get your podcasts